N03.2 Chronic nephritic syndrome with diffuse membranous glomerulonephritis

Name of the Condition

• Chronic Nephritic Syndrome with Diffuse Membranous Glomerulonephritis

Summary

Chronic nephritic syndrome with diffuse membranous glomerulonephritis is a kidney disorder characterized by persistent inflammation of the glomeruli, the kidney's filtering units. This subtype involves diffuse thickening of the glomerular basement membrane due to immune complex deposits, leading to gradual loss of kidney function over time. Common manifestations include hematuria (blood in urine), proteinuria (excess protein in urine), and hypertension. The condition progresses slowly and requires long-term management to preserve renal function.

Causes

Chronic nephritic syndrome with diffuse membranous glomerulonephritis is typically caused by immune-mediated damage to the glomeruli. The exact trigger may involve underlying autoimmune diseases, infections, or exposure to certain medications. In many cases, the condition is idiopathic, meaning the specific cause remains unidentified despite evidence of ongoing immune complex deposition in the kidneys.

Risk Factors

• Autoimmune disorders: Conditions like systemic lupus erythematosus or rheumatoid arthritis.
• Infections: Chronic or recurrent infections that may trigger immune responses.
• Medications: Long-term use of drugs known to cause nephrotoxicity or immune reactions.
• Genetic predisposition: Family history of glomerular diseases or inherited immune disorders.

Symptoms

• Hematuria (visible or microscopic blood in urine).
• Proteinuria (excess protein in urine, often leading to foamy urine).
• Edema (swelling in the legs, ankles, or face).
• Hypertension (high blood pressure).
• Reduced kidney function (e.g., elevated creatinine or BUN levels).

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory tests, and imaging. Urinalysis detects hematuria and proteinuria, while blood tests assess kidney function and rule out other causes. A kidney biopsy is often performed to confirm diffuse membranous glomerulonephritis by identifying immune complex deposits and thickening of the glomerular basement membrane. Imaging studies, such as ultrasound, may evaluate kidney structure and size.

Treatment Options

Treatment focuses on managing symptoms and slowing disease progression. Immunosuppressive medications (e.g., corticosteroids or other agents) may be used to reduce inflammation. Blood pressure control with ACE inhibitors or ARBs helps protect kidney function. Dietary modifications, such as reduced salt and protein intake, may be recommended. In advanced cases, dialysis or kidney transplantation may become necessary.

Prognosis and Follow-Up

Prognosis varies depending on the severity of kidney damage and response to treatment. Early intervention can slow progression, but chronic nephritic syndrome often leads to gradual renal decline over years. Regular follow-up with nephrology is essential to monitor kidney function, adjust medications, and manage complications. Lifelong surveillance is typically required.

Complications

• Progressive kidney failure requiring dialysis or transplantation.
• Hypertension and cardiovascular disease.
• Edema and fluid overload.
• Increased risk of infections due to impaired immune function.

Lifestyle & Prevention

• Maintain a balanced diet low in sodium and protein.
• Control blood pressure and blood sugar levels.
• Avoid nephrotoxic medications (e.g., NSAIDs) unless prescribed.
• Stay hydrated and manage infections promptly.
• Regular exercise and weight management to support overall health.

When to Seek Professional Help

Seek medical attention if you experience persistent hematuria, foamy urine, unexplained swelling, or high blood pressure. Prompt evaluation is critical if kidney function declines rapidly or if symptoms worsen despite treatment. Early intervention can improve outcomes and prevent irreversible damage.

Tips for Medical Coders

When coding for chronic nephritic syndrome with diffuse membranous glomerulonephritis, use ICD-10-CM code N03.2. Ensure documentation supports the diagnosis, including biopsy findings or clinical criteria for membranous glomerulonephritis. Differentiate from other nephritic syndromes by verifying the presence of diffuse glomerular changes. Code accurately to reflect the specific subtype and any associated conditions (e.g., hypertension or proteinuria) for comprehensive reporting.